FDA advisors suggest returning the original Covid vaccine with bivalent omicron trials for all amounts

January 30, 2023: -On Thursday, the Food and Drug Administration’s independent advisory committee recommended which replaces Pfizer and Moderna’s actual Covid vaccine used in the U.S. for the people’s first two immunizations with the recent bivalent omicron trials.

If the FDA accepts the advisors’ suggestions, the U.S. would likely phase out the firms’ vaccines developed against the original Covid-19 strain emerging in Wuhan, China.

Although, the drugmakers’ bivalent omicron attempts that target the omicron BA.5 subvariant and the original strain would be used for the whole vaccination series.

Now, Pfizer’s and Moderna’s omicron shots are authorized as an improvement, while the first two doses are still their old ones based on the original Covid strain.

The committee’s 21 members backed the proposal, which agreed that it would simplify the U.S. Covid vaccination program.

“This is the right thing to do for the situation. It will make things simpler,” stated Dr Melinda Wharton, a senior national official of the National Center for Immunization and Respiratory Diseases, a Centers for Disease Control and Prevention division.

The proposed change would affect people who have yet to receive their two-dose primary vaccination series. No timeline was provided for this switch if the FDA accepted the panel’s nonbinding recommendation.

The suggestion to adopt a single formulation all over the doses comes as the FDA is willing to streamline Covid vaccination so that the system is much easy for the public and healthcare workers to understand.

“The overall idea here is that getting towards one vaccine composition for everyone will be much more helpful,” Dr Peter Marks, the head of the FDA’s vaccine division, stated.

The FDA proposes moving to a system that matches how the agency updates and rolls out flu shots yearly. The agency would adopt a Covid vaccine formulation in June to target the variant expected to dominate in the fall and winter. All manufacturers would use that formulation for all doses.